Home » Tenders » Europe » Germany » Openhouse Process - Div. Active Substances from October 1st, 2020 Tender, Germany - 43507983

Openhouse Process - Div. Active Substances from October 1st, 2020 Tender, Germany - 43507983

Download Documents

AOK RHINELAND / HAMBURG - THE HEALTH INSURANCE FUND has floated a tender for Openhouse Process - Div. Active Substances from October 1st, 2020. The project location is Germany and the tender is closing on 15 Aug 2022. The tender notice number is 214662-2020, while the TOT Ref Number is 43507983. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Procurement Summary

Country : Germany

Summary : Openhouse Process - Div. Active Substances from October 1st, 2020

Deadline : 15 Aug 2022

Other Information

Notice Type : Tender

TOT Ref.No.: 43507983

Document Ref. No. : 214662-2020

Competition : ICB

Financier : Self Financed

Purchaser Ownership : -

Tender Value : Refer Document

Purchaser's Detail

Purchaser : AOK RHINELAND / HAMBURG - THE HEALTH INSURANCE FUND
Address: Kasernenstrasse. 61 Town: Dusseldorf
NUTS code: DE - GERMANY
Postal Code: 40213
Contact Point: Pharmaceuticals / Pharmacies division
Germany
Email :open-house@rh.aok.de
URL :www.aok.de/rh

Tender Details

Document Type: Corrigendum / Additional information (Please refer tender document)

Title: OpenHouse process - Div. Active substances from October 1st, 2020

Reference Number: 2020 - Pharmaceuticals / Pharmacies division

Contract Type: Supplies

Description: Conclusion of non-exclusive discount agreements in accordance with Section 130 a (8) SGB V with the possibility of concluding at any time within the framework of the so-called "OpenHouse process" for various active pharmaceutical ingredients with the earliest possible start of the contract on October 1, 2020.

The specific active pharmaceutical ingredients and the respective start of contracts can be found in the current list of active pharmaceutical ingredients in the project room of the procurement portal dtvp under the heading "Procurement documents".

On October 1, 2020, contracts will be offered for the following active ingredients:

- abacavir;

- abacavir / dolutegravir / lamivudine;

- abacavir / lamivudine / zidovudine;

- abatacept;

- acetylcysteine RX;

- acetylcysteine non-RX;

- Acetylsalicylic acid exclusively according to Annex 1 AM-RL G-BA products;

- acitretin;

- adalimumab;

- alitretionin;

- ambrisentan;

- Amphotericin B;

- Anagrelide except N3 packs from DAR HKP ...